The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance.

about

New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases.Apoptosis and non-alcoholic fatty liver diseases.The Structure and Biological Function of CREG

P2860

Q45932834-079C0084-BA48-4354-B049-57D01294D9B6 Q55503094-64340685-6E0C-440C-8807-C0181B3E68D2 Q58707931-9936FEEC-7B1E-4F74-9AB8-C22AA25DF7A9

P2860

The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance.

Item

http://www.wikidata.org/entity/Q38288136

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The novel intracellular protei ...... esity, and insulin resistance.

@en

type

Item

label

The novel intracellular protei ...... esity, and insulin resistance.

@en

prefLabel

The novel intracellular protei ...... esity, and insulin resistance.

@en

P1476

The novel intracellular protei ...... esity, and insulin resistance.

@en

P2093

Cheng-Hui Yan

http://www.w3.org/2001/XMLSchema#string

Ling-Ping Zhao

http://www.w3.org/2001/XMLSchema#string

Pi-Xiao Wang

http://www.w3.org/2001/XMLSchema#string

Quan-Yu Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-Xiang Tian

http://www.w3.org/2001/XMLSchema#string

Ya-Ling Han

http://www.w3.org/2001/XMLSchema#string

Yan-Xia Liu

http://www.w3.org/2001/XMLSchema#string

Yang Li

http://www.w3.org/2001/XMLSchema#string

P2860

The interaction of hepatic lipid and glucose metabolism in liver diseases

CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease

From NAFLD in clinical practice to answers from guidelines

Nanoporous CREG-eluting stent attenuates in-stent neointimal formation in porcine coronary arteries

Signal transduction by the JNK group of MAP kinases

JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity

Current efforts and trends in the treatment of NASH

Use and abuse of HOMA modeling

A central role for JNK in obesity and insulin resistance

NAFLD and liver transplantation: Current burden and expected challenges.

P304

834-854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.29257

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28508477

http://www.w3.org/2001/XMLSchema#string

P921

Adipositas

The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance.

about

P2860

P2860

The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921